Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551
Date first appeared online 31/05/2017
DOI 10.1080/03007995.2017.1336432
Authors Stephens J.
Journal Name Current Medical Research and Opinion
Volume

Documents